David C. Klonoff, M.D. is an endocrinologist specializing in diabetes technology. He is the Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Health Services in San Mateo, California and a Clinical Professor of Medicine at UCSF. Dr. Klonoff received an FDA Director’s Special Citation Award in 2010 for outstanding contributions related to diabetes technology. He has been cited as being in the top 1% of endocrinologists nationally by Castle Connolly Medical Ltd. and as best endocrinologist in San Mateo County by Bay Area Consumer Checkbook. In 2012 Dr. Klonoff was elected as a Fellow of the American Institute of Medical and Biological Engineering (AIMBE) and cited as one of the 1000 top bioengineers in the world, as well as among the top 2% of the world’s bioengineers for his engineering work in diabetes technology. He received the 2012 Gold Medal Oration and Distinguished Scientist Award from the Dr. Mohan’s Diabetes Specialities Centre and Madras Diabetes Research Foundation of Chennai, India. Dr. Klonoff is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology. He has authored over 200 publications. Dr. Klonoff founded the Diabetes Technology Meeting, the US and European Clinical Diabetes Technology Meetings, the Tissue Response to Implanted Medical Devices Meeting, and the International Hospital Diabetes Meeting. He was the lead investigator for the first randomized controlled multicenter trial of an outpatient closed loop control product, and published the results in the New England Journal of Medicine. Dr. Klonoff chaired the scientific advisory board for the first FDA-cleared insulin patch pump and participated in developing the first FDA-cleared dedicated diabetes telemedicine system, the two FDA-approved inhaled insulins, and the first three FDA-approved incretin drugs for diabetes. He is currently an advisor to Google for their smart contact lens project. Dr. Klonoff has chaired or served on grant review panels for NIH, CDC, NASA, NSF, US Army, ADA, JDRF, and U of Michigan. Dr. Klonoff is a graduate of UC Berkeley, where he was elected to Phi Beta Kappa in his junior year, and UCSF Medical School, where he was elected to Alpha Omega Alpha in his junior year. His postgraduate training included two years at UCLA Hospital and three years at UCSF Hospitals. He was a member of the NIH Diabetes Interagency Coordinating Committee, whose ten-year research plan was released in 2011. Dr. Klonoff chaired the Endocrine Society Task Force on CGM Clinical Guidelines, the CLSI Subcommittee on CGM Metrics (POCT5), and the Diabetes Technology Society/FDA/ADA/Endocrine Society/AAMI Error Grid Panel. Dr. Klonoff currently chairs the Surveillance of FDA-Cleared Blood Glucose Monitors Program to determine the performance of cleared monitors. He is a member of the NSBRI Board of Scientific Counselors and the NASA Exploration Medical Capabilities Standing Review Panel.